Patent · US Active

Polymorphic forms of a macrocyclic inhibitor of HCV

US8143402B2 · kind B2 · utility

0Cited by

1References

26Claims

0Family size

Assignee

Tibotec Pharmaceuticals Ltd. · IE

Inventors

Sigrid Carl Maria Stokbroekx · Beerse, BE
Carina Leys · Stabroek, BE
Kelly Ann Swinney · Boston, US
Stijn Wuyts · Oostham, BE
Andras Horvath · Turnhout, BE

Key dates

Filing date	Feb 1, 2008
Grant date	Mar 27, 2012
Priority date	—
Expiry date	Jan 12, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are crystalline forms of the compound of formula (I), which is a macrocyclic inhibitor of HCV, processes for the preparation thereof, and pharmaceutical compositions comprising these crystalline forms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.